Clinical Trials Logo

Keratoconus clinical trials

View clinical trials related to Keratoconus.

Filter by:

NCT ID: NCT01809977 Completed - Keratoconus Clinical Trials

Comparison of Partial Removal and Total Removal of the Corneal Epithelium on Keratoconus

Start date: July 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine which surgical method makes less corneal haze

NCT ID: NCT01743443 Completed - Keratoconus Clinical Trials

Corneal Sensitivity Cross-linking Keratoconus

CSK
Start date: March 2009
Phase: Phase 2/Phase 3
Study type: Interventional

To evaluate corneal sensitivity changes following corneal cross-linking (CXL) in patients with progressive lower stage keratoconus.

NCT ID: NCT01726283 Completed - Risk of Ectasia Clinical Trials

Combined CXL//UV and PRK or LASIK in Forme Fruste Keratoconus or Eyes With Potential Risk of Ectasia

Start date: October 2011
Phase: N/A
Study type: Observational

This study is being performed to evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) in strengthening and optimizing the biomechanical and biochemical stability of the cornea in patients with fruste keratoconus (FFKC), corneas that are suspicious for FFKC and corneas thought to be at higher risk of developing ectasia that will be undergoing laser vision correction.

NCT ID: NCT01695811 Completed - Keratoconus Clinical Trials

Femtosecond Laser-Assisted Keratoplasty

FLAK
Start date: November 2007
Phase: N/A
Study type: Observational

The purpose of this study will be to determine optimal surgical technique for performing FLAK including laser parameters, keratoplasty shape and suture technique in order to standardize surgical technique and to collect safety and efficacy data. This will be compared to data of patients with full thickness PKP to measure visual outcomes, refraction, astigmatism, surgical methods and wound healing.

NCT ID: NCT01691651 Completed - Keratoconus Clinical Trials

Botulinum Toxin A for the Treatment of Keratoconus

Start date: September 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to associate the use of botulinum toxin type A for patients with keratoconus to demonstrate that tension eyelid has an important role in disease progression.

NCT ID: NCT01686906 Completed - Clinical trials for Advanced Keratoconus

Isolated Bowman Layer Graft for Reducing and Stabilizing Advanced Keratoconus

Start date: January 2011
Phase: N/A
Study type: Interventional

To evaluate the efficacy of mid-stromal implantation of an isolated Bowman layer graft, to reduce and stabilize ectasia in eyes with advanced keratoconus

NCT ID: NCT01672814 Completed - Keratoconus Clinical Trials

Microwave Treatment and Corneal Collagen Crosslinking for Keratoconus

Start date: August 2012
Phase: Phase 3
Study type: Interventional

This study compares the outcomes of the Vedera KXS procedure (a microwave-based procedure, also known as Keraflex) combined with corneal collagen crosslinking to corneal collagen crosslinking alone for the treatment of keratoconus. The goal is to improve corneal shape in patients with keratoconus.

NCT ID: NCT01654614 Completed - Clinical trials for Forme Fruste Keratoconus (FFK)

Diagnostic Capacity of Keratoconus Match Index and Keratoconus Match Probability in Forme Fruste Keratoconus

Start date: November 2011
Phase: N/A
Study type: Observational

Primary objective of this study was to evaluate the diagnostic capability of keratoconus match index (KMI) and keratoconus match probability (KMP) indexes in forme fruste keratoconus (FFK), and their association with a series of Pentacam-derived keratconus (KC) indexes. KMI and KMP parameters are KC-specifc indexes that are measured by Ocular Response Analyzer (ORA), based on the distinct ORA-derived waveform characteristics of KC eyes. Study participants were recruited from the Cornea Outpatient service in a consecutive if eligible basis. Two study groups were formed: a) FFK group (FFKG) that included patients diagnosed with FFK, and, b) Control group (CG) was formed by refractive surgery candidates. All ORA (Reichert Ophthalmic Instrument, Buffalo, NY, USA, software version: 3.01)and Pentacam (Pentacam HR, Oculus Optikgerate GmbH, Heidelberg, Germany)measurements were performed by the same experienced operator in a consistent way

NCT ID: NCT01643226 Completed - Keratoconus Clinical Trials

Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus

Start date: July 2012
Phase: Phase 3
Study type: Interventional

The objectives of this study are to evaluate the safety and efficacy of corneal collagen cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System as compared to placebo in impeding the progression of, and/or reducing, maximum corneal curvature.

NCT ID: NCT01527721 Completed - Keratoconus Clinical Trials

Blurring Strength & Aberrometric Changes Following Corneal Cross-linking (CxL) and CxL Combined With Photorefractive Keratectomy (PRK) in Keratoconus

Start date: September 2010
Phase: N/A
Study type: Interventional

Primary objective of this study was to assess the impact of the two prevalent therapeutic options, CxL and CxL combined with topography-guided photorefractive keratectomy (t-PRK), on both anterior and posterior corneal High order aberations (HOAs).